Actively Recruiting
Led by The Christie NHS Foundation Trust · Updated on 2025-12-02
72
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating whether the Magnetic Resonance Linear Accelerator (MRL) can speed up radiotherapy treatment for patients with Metastatic Spinal Cord Compression (MSCC). The study aims to see if treatment can be successfully delivered in a single one-hour appointment on the MRL compared to the standard care pathway requiring two separate visits: a planning CT scan and a radiotherapy appointment. The trial also explores whether treatment with the MRL can be given within 24 hours from the decision to treat and assesses patient satisfaction through questionnaires. Participants will receive radiotherapy with a prescribed dose of 8 Gray in one treatment using a single posterior-anterior beam. One group will have this treatment delivered on the MRL in a single session without the need for a prior planning CT scan, while the comparison group will follow the standard care pathway involving a planning CT appointment before radiotherapy. The study includes an optional diversity questionnaire prior to treatment and a patient experience questionnaire completed on the day of treatment. Treatment timings and patient outcomes will be monitored up to 12 months after therapy. Participants will be followed through clinical notes at 1, 3, 6, and 12 months after treatment to record their well-being and function. The study involves a recruitment period of two years with follow-up lasting one additional year. Data collected includes the timing from decision to treat to completion of therapy, patient consent times, and patient-reported experience. Participants are free to withdraw from the trial at any time without penalty.
CONDITIONS
To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compression (MSCC) on the Magnetic Resonance Linear Accelerator (MRL) in a Single Appointment and Compare it to the Standard of Care Radiotherapy Pathway
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 1 day
Participants are screened for eligibility to participate in the trial.
1 screening visit (in-person)
Duration - Up to 7 days from consent to treatment completion
Participants receive radiotherapy treatment for metastatic spinal cord compression either using the MR Linac in a single appointment without a prior planning CT scan or the standard pathway with a planning CT followed by radiotherapy.
1 treatment visit (in-person), plus 1 planning CT visit for standard care participants
Duration - 12 months
Participants complete a patient experience questionnaire on the day of treatment and clinical outcomes are monitored from clinical notes up to 12 months after treatment.
Follow-up assessments at 1, 3, 6, and 12 months post-treatment
Total: 1 location
1
The Christie NHS Foundation Trust
Manchester, United Kingdom, M20 4BX
Actively Recruiting
C
Clinical Trial Radiographer
A
Alice Greenwood-Wilson
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Kristina Olausson, Annette Holst Hansson, Björn Zackrisson...
https://pubmed.ncbi.nlm.nih.gov/32095560Helen Barnes, Sophie Alexander, Lorna Bower...
https://pubmed.ncbi.nlm.nih.gov/34307911Rosie B Hales, John Rodgers, Lee Whiteside...
https://pubmed.ncbi.nlm.nih.gov/32600981Rebecca Benson, Abigael Clough, Claire Nelder...
https://pubmed.ncbi.nlm.nih.gov/34922879